Topical Bimatoprost Solution 0.03%in Stable Vitiligo
NCT01202513
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
20
Enrollment
OTHER
Sponsor class
Stopped
regulatory reasons
Conditions
Vitiligo
Repigmentation
Interventions
DRUG:
Bimatoprost 0.03% topical ophthalmic solution
Sponsor
Gian Sagar Medical College and Hospital